Solid Tumor Clinical Trials
A listing of Solid Tumor medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found 879 clinical trials
KN026 Combined With KN046 in Subjects With HER2 Positive Solid Tumor
advanced HER2 positive solid tumors.
- 0 views
- 24 Apr, 2022
- 1 location
A Phase 1 Study of BPI-28592 in Subjects With Advanced Solid Tumors
This is an open-labe Phase I study of BPI-28592 for the treatment of patients with solid tumors
- 0 views
- 19 Apr, 2022
A Study of EMB-02 in Participants With Advanced Solid Tumors
The primary purpose of this study is to identify the recommended Phase 2 dose(s) (RP2Ds) and schedule assessed to be safe for EMB-02 and to characterize the safety and tolerability of EMB-02 at the RP2Ds. Pharmacokinetics (PK), immunogenicity, and the anti-tumor activity of EMB-02 will also be assessed.
- 0 views
- 24 Apr, 2022
- 6 locations
A Phase I Study of JS108 in Patients With Advanced Solid Tumors
This is a phase I, open-label, first-in-human clinical study designed to evaluate the safety, tolerability, PK profile and efficacy of JS108 for patients with advanced solid tumors. This study
- 0 views
- 19 Apr, 2022
- 3 locations
First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors
recurrent solid tumors or metastatic solid tumors where curative or standard treatment options have been exhausted
- 0 views
- 26 Apr, 2022
- 1 location
A Study of FF-10850 Topotecan Liposome Injection in Advanced Solid Tumors
advanced solid tumors.
- 18 views
- 29 Apr, 2022
- 2 locations
A Study to Evaluate YH001 in Subjects With Advanced Solid Tumors
(RP2D) of YH001 in subjects with advanced solid tumors.
- 0 views
- 12 May, 2022
- 1 location
A Phase 1 Dose-escalation Study of FF-10832 for Treatment of Solid Tumors
) for treatment of advanced solid tumors.
- 50 views
- 02 May, 2022
- 4 locations
A Study to Investigate CYC140, in Subjects With Advanced Solid Tumors and Lymphoma
administered orally daily. This study consists of Phase 1 and Phase 2 components in subjects with advanced solid tumors and lymphoma who have progressed despite having standard therapy or for which no standard
- 0 views
- 09 May, 2022
- 2 locations
Phase 1/2a Study of MPB-1734 in Patients With Advanced Solid Tumors
This is a first-in-human (FIH), multicenter, open-label, uncontrolled, Phase 1/2a study with dose escalation in patients with advanced solid tumors (Part 1) and cohorts of up to 15 patients per
- 0 views
- 10 May, 2022
- 1 location